However, patients with severe dyslipidemia, familial hypercholesterolemia, or very high LDL despite statins require specialist lipid managementGLP-1 therapy is complementary, not a replacement
As mentioned above, clinical guidelines do not recommend DTE products at all
(2024, December 12)
Reported activities include fibroblast stimulation, controlled intracellular copper delivery, modulation of collagen and glycosaminoglycan synthesis, and broad changes in gene expression across stress-response and tissue-repair networks
The main production annual capacity are: Injection: 1 billion ampoules, Powder: 80million bags, Disinfectant: 10 million bottles, Premix: 5000mt
doi:10.1007/s00701-014-2129-2